Severe COVID-19 disease in two pediatric oncology patients.
作者信息
Stokes Claire L, Patel Pratik A, Sabnis Himalee S, Mitchell Sarah G, Yildirim Inci B, Pauly Melinda G
机构信息
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
出版信息
Pediatr Blood Cancer. 2020 Sep;67(9):e28432. doi: 10.1002/pbc.28432. Epub 2020 Jul 6.
Abstract
摘要
相似文献
1
Severe COVID-19 disease in two pediatric oncology patients.
Pediatr Blood Cancer. 2020 Sep;67(9):e28432. doi: 10.1002/pbc.28432. Epub 2020 Jul 6.
2
SARS-Coronavirus-2 and acute urticaria.
Int J Dermatol. 2020 Jul;59(7):867-868. doi: 10.1111/ijd.14950. Epub 2020 May 22.
3
Pediatric Characteristics of 2019 Novel Coronavirus: Review of Available Published Literature.
Clin Pediatr (Phila). 2020 Sep;59(9-10):849-852. doi: 10.1177/0009922820920017. Epub 2020 Apr 15.
4
Myocarditis in a 16-year-old boy positive for SARS-CoV-2.
Lancet. 2020 Jun 27;395(10242):e116. doi: 10.1016/S0140-6736(20)31307-6.
5
A distinctive skin rash associated with coronavirus disease 2019?
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e246-e247. doi: 10.1111/jdv.16471. Epub 2020 Jun 8.
6
Angioedema in COVID-19.
Eur Heart J. 2020 Sep 7;41(34):3283-3284. doi: 10.1093/eurheartj/ehaa452.
7
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Ann Hematol. 2020 Aug;99(8):1951-1952. doi: 10.1007/s00277-020-04130-2. Epub 2020 Jun 11.
8
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence.
Eur J Intern Med. 2020 Jul;77:121-122. doi: 10.1016/j.ejim.2020.04.042. Epub 2020 Apr 23.
9
Hemoptysis as an Initial Presentation of COVID-19 - An Observation.
J Assoc Physicians India. 2020 Jun;68(6):68.
10
SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?
Dig Liver Dis. 2020 Nov;52(11):1244-1245. doi: 10.1016/j.dld.2020.06.047. Epub 2020 Jul 11.
引用本文的文献
1
COVID-19 infection in children with blood cancer: A systematic review.
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
2
A Case Report of Pediatric Germinoma With SARS-CoV-2: Lessons Learned From an Academic Tertiary Referral Hospital in Asian COVID Epicentrum.
Int J Surg Case Rep. 2022 Feb;91:106774. doi: 10.1016/j.ijscr.2022.106774. Epub 2022 Jan 17.
3
COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients.
Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022009. doi: 10.4084/MJHID.2022.009. eCollection 2022.
4
COVID-19 infection in pediatric patients treated for cancer.
Int J Clin Oncol. 2022 Feb;27(2):448-454. doi: 10.1007/s10147-021-02068-7. Epub 2021 Nov 6.
5
Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection.
Front Pediatr. 2021 Aug 2;9:712603. doi: 10.3389/fped.2021.712603. eCollection 2021.
6
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
Bull Cancer. 2021 May;108(5):490-500. doi: 10.1016/j.bulcan.2021.02.004. Epub 2021 Mar 11.
7
Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.
Pediatr Blood Cancer. 2021 Jun;68(6):e29005. doi: 10.1002/pbc.29005. Epub 2021 Mar 15.
8
Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis.
Front Oncol. 2021 Jan 21;10:608282. doi: 10.3389/fonc.2020.608282. eCollection 2020.
9
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
Pediatr Blood Cancer. 2021 Mar;68(3):e28843. doi: 10.1002/pbc.28843. Epub 2020 Dec 18.
10
Hematological manifestations of SARS-CoV-2 in children.
Pediatr Blood Cancer. 2020 Dec;67(12):e28745. doi: 10.1002/pbc.28745. Epub 2020 Oct 3.
本文引用的文献
1
Effective treatment of severe COVID-19 patients with tocilizumab.
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
2
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
3
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati.
Bone Marrow Transplant. 2020 Oct;55(10):1900-1905. doi: 10.1038/s41409-020-0895-4. Epub 2020 Apr 20.
4
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
5
Oncology Practice During the COVID-19 Pandemic.
JAMA. 2020 May 26;323(20):2005-2006. doi: 10.1001/jama.2020.6236.
6
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
7
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426. doi: 10.15585/mmwr.mm6914e4.
8
Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.
Clin Infect Dis. 2020 Jul 28;71(15):896-897. doi: 10.1093/cid/ciaa415.
9
Tocilizumab treatment in COVID-19: A single center experience.
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
10
Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.
Acta Diabetol. 2020 Jun;57(6):759-764. doi: 10.1007/s00592-020-01522-8. Epub 2020 Apr 5.
Zotero 插件